Cholesterol and cardiovascular disease
The DOI matches its Crossref record, with a small difference in title or year; 20 of the 21 references it cites were found in a registry or an index.
Abstract
The Lipid Research Clinics (LRC) Program has implemented an integrated series of observational epidemiologic, community-based studies that provide a frame of reference for the results of the LRC Coronary Primary Prevention Trial (CPPT). The observational studies were performed in 16 populations sampled in the United States, Canada, the Soviet Union and Israel. Findings based on data from more than 80,000 study participants indicate that atherogenic profiles of plasma total, low-density lipoprotein and high-density lipoprotein cholesterol levels are highly prevalent in middle-aged adults. The lipoprotein cholesterol fraction components are related to a wide range of demographic, behavioral, anthropometric, medical status, drug utilization and hormonal factors, in addition to the well known major dietary and genetic determinants. The results of the LRC CPPT are directly applicable to high-risk, high total cholesterol, and high low-density lipoprotein cholesterol levels in middle-aged men. Considered jointly with the observational finding that the major burden of ischemic heart disease is associated with moderately elevated lipid levels, the LRC studies suggest that 2 concurrent approaches are necessary to achieve community control: approaches for high-risk person through individualized medical intervention and hygienic, population-oriented approaches toward achieving less atherogenic distributions of lipids and lipoproteins. With this combined approach, the current epidemic of ischemic heart disease can be controlled.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In clinical trials, bile acid sequestrants have contributed greatly to the original demonstration of the efficacy of LDL-C lowering in reducing CV events in hypercholesterolaemic subjects, with a benefit proportional to the degree of LDL-C lowering.108”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [108]
Citations
Cites
The Framingham Study. The Epidemiology of Atherosclerotic Disease.
(1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-2-286_1 · Cited by 623
Prevention of coronary heart disease.
(1976) · BMJ · doi:10.1136/bmj.1.6014.881 · Cited by 383
Bush, T. L. (1983) · JAMA · doi:10.1001/jama.1983.03330310033022 · Cited by 257
The Framingham Study: The Epidemiology of Atherosclerotic Disease
Levy, R. I. (1981) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1981.03310300064027 · Cited by 223
Genetic analysis of common diseases: Applications to predictive factors in coronary disease
Siervogel, R. M. (1981) · Europe PMC (PubMed Central) · Cited by 133
GARRISON, R. J., CASTELLI, W. P., FEINLEIB, M., KANNEL, W. B., HAVLIK, R. J., PADGETT, S. J., & MCNAMARA, P. M. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112816 · Cited by 106
Prevention of Coronary Heart Disease
Kornitzer, M. (1983) · Springer eBooks · doi:10.1007/978-1-4684-4457-5_14 · Cited by 100
Cardiovascular disease risk factor variables at the preschool age. The Bogalusa heart study.
Berenson, G. S., Foster, T. A., Frank, G. C., Frerichs, R. R., Srinivasan, S. R., Voors, A. W., & Webber, L. S. (1978) · Circulation · doi:10.1161/01.cir.57.3.603 · Cited by 90
Research works printed but not linked: 4
- 1980, US Dept of Health and Human Services publication No. (NIH) 80-1527
- Helss, 1980, The epidemiology of plasma high-density lipoprotein cholesterol levels (summary). The Lipid Research Clinics Program Prevalence Study, Circulation, 62, IV
- Lipid Research Clinics Epidemiology Committee by the Follow-Up Study Executive Committee, 1980, High density lipoprotein cholesterol (HDL-C) as an independent negative risk factor for deaths in a Lipid Research Clinics (LRC) Program population: an interim report at 4 years follow-up (abstr), Am J Epidemiol, 112, 427
- Blackburn, 1979, 8, 612
Cited by
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.012 · Cited by 192
“In clinical trials, bile acid sequestrants have contributed greatly to the original demonstration of the efficacy of LDL-C lowering in reducing CV events in hypercholesterolaemic subjects, with a benefit proportional to the degree of LDL-C lowering.(108) ESC/EAS Guidelines 1791”
Background
Metadata
- Authors
- Tyroler, H. A.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Tyroler, H.A.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1984-08
- Volume
- 54
- Issue
- 5
- Pages
- 14-19
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2140321277
- Cited by
- 52
- References
- 21
- Citations by year
- 2025: 1 · 2022: 1 · 2017: 2 · 2016: 3 · 2013: 3 · 2012: 3
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- cholesterol, cardiovascular disease, ischemic heart disease, plasma lipids, LDL cholesterol, HDL cholesterol, atherogenic lipid profile, middle-aged men, risk factors, community-based prevention
- MeSH terms
- Adolescent, Adult, Aged, Canada, Cholesterol, Clinical Trials as Topic, Coronary Disease, Estrogens, Female, Humans, Israel, Lipoproteins, HDL, Cholesterol, HDL, Lipoproteins, LDL, Cholesterol, LDL, Male, Menopause, Middle Aged, Primary Prevention, United States, USSR
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cholesterol and cardiovascular disease. https://app.cochat.ai/papers/10.1016/0002-9149(84)90851-8
- The paper
- Tyroler, H. A. (1984). Cholesterol and cardiovascular disease. The American Journal of Cardiology. https://doi.org/10.1016/0002-9149(84)90851-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.